Application of thermal analysis to the study of anti-tuberculosis drug compatibility. Part 1

Journal of Thermal Analysis and Calorimetry

Volumn 108, Issue 1, 2012, Pages 207-212

  Lavor, Edilene P ^a   Freire, Fátima Duarte ^a   Aragão, Cícero Flávio S ^a   Raffin, Fernanda N ^a   De Lima E Moura, Túlio Flávio A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Fixed dose combination; Interaction; Thermal analysis; Tuberculostatic drugs

Indexed keywords

CHEMICAL INTERACTIONS; DRUG PREPARATION; DTA CURVES; ETHAMBUTOL; FIXED-DOSE COMBINATION; HEALTH POLICY; HIGH RATE; INTERACTION; PYRAZINAMIDE; THERMAL BEHAVIORS; THERMAL EVENTS; TUBERCULOSTATIC DRUGS;

DRUG DOSAGE; DRUG PRODUCTS; THERMOANALYSIS; TUBES (COMPONENTS);

DRUG INTERACTIONS;

EID: 84858070453     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-011-1770-8     Document Type: Article

References (27)

1. World Health Organization. WHO report 2007. Global tuberculosis control: surveillance, planning, financing, Geneva. World Health Organization; 2007. http://www.who.int/tb/publications/global-report/2008/pdf/fullreport.pdf. Accessed 11 Jan 2010.
2. World Health Organization. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de Controle da Tuberculose-PNCT, 2008. http://www.cve.saude.sp.gov.br. Accessed 2 Feb 2010.
3. S Singh H Bhutani TT Mariappan 2006 Quality problems of anti-tuberculosis fixed-dose combinations (FDCs): a way forward Ind J Tuberc 5 201 205
4. R Bottom 1999 The role of modulated temperature differential scanning calorimetry in the characterisation of a drug molecule exhibiting polymorphic and glass forming tendencies Int J Pharm 192 47 53 10.1016/S0378-5173(99)00271-9 1:CAS:528:DyaK1MXnsVChsr0%3D
5. FM McDaid SA Barker S Fitzpatrick CR Petts DQM Craig 2003 Further investigations into the use of high sensitivity differential scanning calorimetry as a means of predicting drug-excipient interactions Int J Pharm 252 235 240 10.1016/S0378-5173(02)00651-8 1:CAS:528:DC%2BD3sXmtVCrtQ%3D%3D (Pubitemid 36126632)
6. S Singh H Bhutani TT Mariappan H Kaur M Bajaj SP Pakhale 2002 Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. Part 1: pure anti-tuberculosis drugs and their combinations Int J Pharm 245 37 44 10.1016/S0378-5173(02)00340-X 1:CAS:528:DC%2BD38XntFyhu7k%3D
7. SZD Cheng CY Li BH Calhoun L Zhu WW Zhou 2000 Thermal analysis: the next two decades Thermochim Acta 355 59 68 10.1016/S0040-6031(00)00437-8 1:CAS:528:DC%2BD3cXjvF2qu7g%3D
8. Procópio JVV, Souza VG de, Costa RA da, Correia LP, Souza FS de, Macêdo RO. Application of thermal analysis and pyrolysis coupled to GC/MS in the qualification of simvastatin pharmaceutical raw material. J Therm Anal Calorim 2010. doi: 10.1007/s10973-010-1274-y.
9. NM Vemuri Z Chrzan R Cavatur 2004 Use of isothermal microcalorimetry in pharmaceutical preformulation studies. Part I. Monitoring crystalline phase transitions J Therm Anal Calorim 78 47 54 10.1023/B:JTAN.0000042152.77530.ed
10. R Cavatur NM Vemuri Z Chrzan 2004 Use of isothermal microcalorimetry in pharmaceutical preformulation studies. Part III. Evaluation of excipient compatibility of a new chemical entity J Therm Anal Calorim 78 63 72 10.1023/B:JTAN.0000042154.13588.19
11. MF Pinto EA de Moura FS De Souza RO Macêdo 2010 Thermal compatibility studies of nitroimidazoles and excipients J Therm Anal Calorim 102 323 329 10.1007/s10973-010-0889-3 1:CAS:528:DC%2BC3cXhtFartLjP
12. RS Nunes FS Semaan AT Riga ETG Cavalheiro 2009 Thermal behavior of verapamil hydrochloride and its association with excipients J Therm Anal Calorim 97 349 353 10.1007/s10973-009-0072-x 1:CAS:528:DC%2BD1MXht1OgurvK
13. MN Freitas R Alves JR Matos JM Marchetti 2007 Thermal analysis applied in the osmotic tablets pre-formulation studies J Therm Anal Calorim 87 905 911 10.1007/s10973-006-7710-3 1:CAS:528:DC%2BD2sXis1Kntb4%3D (Pubitemid 46399307)
14. FD Freire CFS Aragão TA de Le Moura FN Raffin 2009 Compatibility study between chlorpropamide and excipients in their physical mixtures J Therm Anal Calorim 97 355 357 10.1007/s10973-009-0258-2 1:CAS:528:DC%2BD1MXht1OgurzI
15. FD Freire CFS Aragão TA de Le Moura FN Raffin 2009 Thermal studies of isoniazid and mixtures with rifampicin J Therm Anal Calorim 97 333 336 10.1007/s10973-009-0084-6 1:CAS:528:DC%2BD1MXht1Ogur3M
16. SG Avula K Alexander AT Riga 2010 Predicting eutectic behavior of drugs and excipients by unique calculations J Therm Anal Calorim 99 655 658 10.1007/s10973-009-0595-1 1:CAS:528:DC%2BC3cXhsFGqu7s%3D
17. Aigner Z, Heinrich R, Sipos E, Farkas G, Ciurba A, Berkesi O, Szabó-Révész P. Compatibility studies of aceclofenac with retard tablet excipients by means of thermal and FT-IR spectroscopic methods. J Therm Anal Calorim. 2010. doi: 10.1007/s10973-010-1105-1.
18. Tita B, Fulias A, Szabadai Z, Rusu G, Bandur G, Tita D. Compatibility study between ibuprofen and excipients in their physical mixtures. J Therm Anal Calorim. 2010. doi: 10.1007/s10973-010-1188-8.
19. Tita D, Fulias A, Tita B. Thermal stability of ketoprofen-active substance and tablets. J Therm Anal Calorim. 2010. doi: 10.1007/s10973-010-1187- 9.
20. RAE Castro TMR Maria AOL Évora JC Feiteira MR Silva AM Beja J Canotilho MES Eusébio 2010 A new insight into pyrazinamide polymorphic forms and their thermodynamic relationships Cryst Growth Des 10 274 282 10.1021/cg900890n 1:CAS:528:DC%2BD1MXhsFShsrfK
21. CD Bertol AP Cruz HK Stulzer FS Murakami MAS Silva 2010 Thermal decomposition kinetics and compatibility studies of primaquine under isothermal and non-isothermal conditions J Therm Anal Calorim 102 187 192 10.1007/s10973-009-0540-3 1:CAS:528:DC%2BC3cXhtFartL7J
22. S Agrawal Y Ashokraj PV Bharatam O Pillai R Panchagnula 2004 Solid-state characterization of rifampicin samples and its biopharmaceutic relevance Eur J Pharm Sci 22 127 144 10.1016/j.ejps.2004.02.011 1:CAS:528:DC%2BD2cXkt1Sltbg%3D (Pubitemid 38668679)
23. Alves R. Estudo termoanalítico e de compatibilidade fármaco-excipiente de rifampicina e alguns medicamentos utilizados na terapêutica da tuberculose. Dissertation, Postgraduate in in drugs and medicines, USP, 2007.
24. B Prasad H Bhutani V Kumar S Singh 2007 A new validated differential scanning calorimetric procedure for monitoring the less active r, s isomer of ethambutol dihydrochloride in bulk drug samples and anti-tuberculosis formulations Pharm Forum 33 326 333 (Pubitemid 351780887)
25. M Wesolowski T Konarski 1995 Characteristics of the thermal decomposition of antituberculosis drugs J Therm Anal Calorim 45 1199 1204 10.1007/BF02547494 1:CAS:528:DyaK28XhtF2ktA%3D%3D
26. Y Takaki Y Sasada T Watanabe 1960 The crystal structure of 2-pyrazinamide Acta Crystallogr 13 693 702 10.1107/S0365110X60001680 1:CAS:528: DyaF3cXht1ektLg%3D
27. H Bhutani S Singh KC Jindal 2005 Drug-drug interaction studies on first-line anti-tuberculosis drugs Pharm Dev and Techn 10 517 524 10.1080/10837450500299982 1:CAS:528:DC%2BD2MXht1GltLjL (Pubitemid 41770036)